Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy.

× No keyword cloud information.

31 in total

Review 1. First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors: Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal: J Pharm Sci Date: 2011-04-11 Impact factor: 3.534

2. Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population.

Authors: Ya-Li Nie; Hang He; Jiang-Feng Li; Xiang-Guang Meng; Liang Yan; Pei Wang; Shu-Jie Wang; Hong-Zheng Bi; Li-Rong Zhang; Quan-Cheng Kan
Journal: Eur J Clin Pharmacol Date: 2016-10-05 Impact factor: 2.953

Review 3. DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Authors: S Solier; Y-W Zhang; A Ballestrero; Y Pommier; G Zoppoli
Journal: Curr Cancer Drug Targets Date: 2012-05 Impact factor: 3.428

Review 4. Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.

Authors: Dong Dong; Roland Ako; Ming Hu; Baojian Wu
Journal: Xenobiotica Date: 2012-03-02 Impact factor: 1.908

5. Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

Authors: Baojian Wu; Shuxing Zhang; Ming Hu
Journal: Mol Pharm Date: 2011-10-21 Impact factor: 4.939

6. Pharmacogenomics: time to rethink its role in precision medicine.

Authors: J A Willis; E Vilar
Journal: Ann Oncol Date: 2018-02-01 Impact factor: 32.976

Review 7. Pharmacogenomics in early-phase clinical development.

Authors: Tal Burt; Savita Dhillon
Journal: Pharmacogenomics Date: 2013-07 Impact factor: 2.533

Review 8. Interindividual differences in response to plant-based diets: implications for cancer risk.

Authors: Johanna W Lampe
Journal: Am J Clin Nutr Date: 2009-03-18 Impact factor: 7.045

9. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.

Authors: Nicholas W Choong; Everett E Vokes; Daniel J Haraf; Peter K Tothy; Mark K Ferguson; Kristen Kasza; Charles M Rudin; Philip C Hoffman; Stuart A Krauss; Livia Szeto; Ann M Mauer
Journal: J Thorac Oncol Date: 2008-01 Impact factor: 15.609

10. XELIRI regimen plus continuous treatment with bevacizumab is well-tolerated and effective in metastatic colorectal cancer patients in a second-line setting involving the sequential administration of XELOX and XELIRI.

Authors: Koichi Suzuki; Kato Takaharu; Yuta Muto; Kosuke Ichida; Taro Fukui; Yuji Takayama; Shingo Tsujinaka; Junichi Sasaki; Hisanaga Horie; Yutaka J Kawamura; Fumio Konishi; Toshiki Rikiyama
Journal: Mol Clin Oncol Date: 2014-06-06